Skip to main content
Premium Trial:

Request an Annual Quote

Catholic Health Initiative Selects BioFortis’ Labmatrix for Personalized Medicine Research


BioFortis said this week that the Catholic Health Initiatives’ Institutes for Research and Innovation’s Center for Translational Research will use its Labmatrix software for workflow-driven protocols, specimen biobanking, next generation diagnostics, biomarker discovery, and translational research aimed at advancing the center’s personalized medicine research efforts.

BioFortis’ Labmatrix is a web-based software that lets users manage and integrate clinical, specimen, and molecular assay datasets and interface the data with other systems such as electronic medical records, genomic or proteomic databases, and laboratory information management systems.

BioFortis said that once the software is deployed, the center’s physicians and scientists can “explore and ask complex questions about the collected data,” which is expected to lead to “faster formulation and better utilization” of clinical and molecular assay data and ultimately lead to better treatment options for patients.

In addition, the partners plan to integrate the software with in-network hospitals’ electronic medical records systems.

Jeff Otto, CTR’s national director, said that Labmatrix will allow “CTR and its partners to trust the answers that flow from our research while protecting the privacy of our specimen donors.”

CTR is a clinical research, development and molecular diagnostics laboratory that supports the development of personalized medicine-centered research in the 72 hospitals that make up CHI's community-based healthcare system.

The Scan

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.

Tumor Microenvironment Immune Score Provides Immunotherapy Response, Prognostic Insights

Using multiple in situ analyses and RNA sequence data, researchers in eBioMedicine have developed a score associated with immunotherapy response or survival.

CRISPR-Based Method for Finding Cancer-Associated Exosomal MicroRNAs in Blood

A team from China presents in ACS Sensors a liposome-mediated membrane fusion strategy for detecting miRNAs carried in exosomes in the blood with a CRISPR-mediated reporter system.

Drug Response Variants May Be Distinct in Somatic, Germline Samples

Based on variants from across 21 drug response genes, researchers in The Pharmacogenomics Journal suspect that tumor-only DNA sequences may miss drug response clues found in the germline.